Nitrogen

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may render it contraindicated in certain circumstances. There are no specific teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

For administration, Nitrogen is intended for use exclusively by or under the supervision of a licensed practitioner experienced in its use and administration.

The route of administration is via respiratory inhalation. The active ingredient is Nitrogen, provided in a concentration of 990 mL within a 1 L container.

Healthcare professionals should ensure that the administration is conducted in a controlled environment, adhering to established safety protocols and guidelines for inhalation therapies.

Contraindications

Use of this product is contraindicated in situations where safety precautions have not been fully understood and implemented. Additionally, the valve must not be opened until it is securely connected to the appropriate equipment prepared for use.

Warnings and Precautions

Administration of Nitrogen may pose significant hazards and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses experience in the administration of Nitrogen. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazardous Properties Nitrogen is classified as a gas under pressure and may explode if subjected to heat. Additionally, it has the potential to displace oxygen in the environment, leading to rapid suffocation. Therefore, it is crucial that all safety precautions are thoroughly read and understood prior to handling.

Storage and Usage Precautions Nitrogen should only be used and stored outdoors or in a well-ventilated area. A backflow preventive device must be employed in the piping to mitigate risks. The valve should be closed after each use and when the cylinder is empty. Equipment utilized must be rated for cylinder pressure, and the valve should not be opened until it is securely connected to the appropriate equipment. Furthermore, protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). It is essential to read and adhere to the Safety Data Sheet (SDS) before use.

First Aid Measures In the event of inhalation, the affected individual should be removed to fresh air and kept comfortable for breathing. Medical advice or attention should be sought immediately.

Emergency Medical Assistance If inhalation occurs, it is critical to obtain medical advice or attention without delay.

Side Effects

Patients may experience serious adverse reactions, including the potential for oxygen displacement, which can lead to rapid suffocation. In the event of inhalation, it is critical to remove the individual to fresh air and ensure they are kept comfortable for breathing. Medical advice and attention should be sought immediately following such exposure.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Administration of Nitrogen during pregnancy may pose significant risks and is generally considered hazardous or contraindicated. The use of Nitrogen should be restricted to licensed practitioners who possess experience in its administration.

Pregnant patients should be made aware that Nitrogen is stored under pressure and may explode if subjected to heat. Additionally, the gas can displace oxygen, leading to rapid suffocation, which poses a serious risk to both the mother and the fetus.

It is imperative that all safety precautions are thoroughly read and understood prior to handling Nitrogen. The gas should only be used and stored outdoors or in well-ventilated areas to minimize the risk of exposure. Healthcare professionals are advised to consult the Safety Data Sheet (SDS) for detailed safety information before use.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further research may be necessary to determine the safety profile in this population.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the drug insert for Nitrogen. Healthcare professionals should exercise caution and consider individual patient factors when prescribing this medication to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrogen. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this population. It is recommended that healthcare providers exercise caution when prescribing Nitrogen to patients with compromised liver function, given the lack of data on its safety and efficacy in this group. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not outlined in the prescribing information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while no specific overdosage information is provided, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated in certain situations. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must emphasize the warning that Nitrogen contains gas under pressure and may explode if heated. Patients should be informed that Nitrogen can displace oxygen, potentially leading to rapid suffocation. Therefore, it is crucial that patients do not handle Nitrogen until they have read and understood all safety precautions.

Patients should be instructed to use and store Nitrogen only outdoors or in a well-ventilated area. The use of a backflow preventive device in the piping is recommended to ensure safety. Additionally, patients should be reminded to close the valve after each use and when the cylinder is empty. It is important to use Nitrogen only with equipment that is rated for cylinder pressure and to avoid opening the valve until it is connected to the appropriate equipment prepared for use.

Healthcare providers should also inform patients to protect Nitrogen from sunlight when the ambient temperature exceeds 52°C (125°F) and to read and follow the Safety Data Sheet (SDS) prior to use. In the event of inhalation, patients should be advised to remove themselves to fresh air and maintain comfort for breathing, while seeking medical advice or attention as necessary.

Storage and Handling

The product is supplied in a manner that ensures safe handling and storage. It is essential to use and store the product exclusively outdoors or in a well-ventilated area to minimize risks associated with exposure. When ambient temperatures exceed 52°C (125°F), the product must be protected from direct sunlight to maintain its integrity.

After each use and when the product is empty, the valve should be securely closed to prevent any unintended release. It is critical not to open the valve until it is connected to equipment that is prepared for use, ensuring that all safety protocols are followed. The product should only be utilized with equipment that is rated for cylinder pressure to ensure safe operation.

Additionally, a backflow preventive device must be employed in the piping to safeguard against potential hazards. Prior to use, it is imperative to read and adhere to the Safety Data Sheet (SDS) to ensure comprehensive understanding of the product's handling and safety requirements.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by TIMS SOUTH TEXAS LLC. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)